Skip to Main Content

Paper Details

Phase I trial of TRC102 (methoxyamine HCl) in combination with temozolomide in patients with relapsed solid tumors and lymphomas.
Oncotarget
6
2020
AP endonuclease, BACKGROUND, H2AX, HCl, MGMT, MMR protein, O6-methylguanine, O6-methylguanine DNA methyltransferase, Rad51, TRC 102, TRC102, abasic sites, anemia, cell line, colon cancer, granulosa cell ovarian cancer, lymphomas, lymphopenia, methoxyamine, neutropenia, non-small cell lung cancer, p53, pNBs1, patient, patients, solid tumors, temozolomide
Author NameAffiliation
Toshinori HinoueVan Andel Institute, Center for Epigenetics
Peter W LairdVan Andel Institute, Center for Epigenetics
Peter W LairdVan Andel Institute, Center for Epigenetics
James H Doroshowand Center for Cancer Research, National Cancer Institute, National Institutes of Health
James H Doroshowand Center for Cancer Research, National Cancer Institute, National Institutes of Health
  • 1 - 5

Datasets

Release 1.2